Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer.

Abduljabbar R, Al-Kaabi MM, Negm OH, Jerjees D, Muftah AA, Mukherjee A, Lai CF, Buluwela L, Ali S, Tighe PJ, Green A, Ellis I, Rakha E.

Breast Cancer Res Treat. 2015 Mar 21. [Epub ahead of print]

PMID:
25794775
2.

Clinically derived early postoperative pain trajectories differ by age, sex, and type of surgery.

Tighe PJ, Le-Wendling LT, Patel A, Zou B, Fillingim RB.

Pain. 2015 Apr;156(4):609-17. doi: 10.1097/01.j.pain.0000460352.07836.0d.

PMID:
25790453
3.

Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.

Abduljabbar R, Negm OH, Lai CF, Jerjees DA, Al-Kaabi M, Hamed MR, Tighe PJ, Buluwela L, Mukherjee A, Green AR, Ali S, Rakha EA, Ellis IO.

Breast Cancer Res Treat. 2015 Apr;150(2):335-46. doi: 10.1007/s10549-015-3335-1. Epub 2015 Mar 12.

PMID:
25762479
4.

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS.

Acta Physiol (Oxf). 2015 Feb 23. doi: 10.1111/apha.12474. [Epub ahead of print]

PMID:
25704169
5.

The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.

Jerjees DA, Negm OH, Alabdullah ML, Mirza S, Alkaabi M, Hameed MR, Abduljabbar R, Muftah A, Nolan CC, Green AR, Tighe PJ, Band V, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2015 Feb;150(1):91-103. doi: 10.1007/s10549-015-3308-4. Epub 2015 Feb 21.

PMID:
25701120
6.

Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFN╬│/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.

Vilisaar J, Kawabe K, Braitch M, Aram J, Furtun Y, Fahey AJ, Chopra M, Tanasescu R, Tighe PJ, Gran B, Pothoulakis C, Constantinescu CS.

J Neuroimmune Pharmacol. 2015 Feb 18. [Epub ahead of print]

PMID:
25690155
7.

ELISA in the multiplex era: Potentials and pitfalls.

Tighe PJ, Ryder RR, Todd I, Fairclough LC.

Proteomics Clin Appl. 2015 Jan 23. doi: 10.1002/prca.201400130. [Epub ahead of print]

PMID:
25644123
8.

Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease.

Daffa NI, Tighe PJ, Corne JM, Fairclough LC, Todd I.

Clin Exp Immunol. 2015 Apr;180(1):155-63. doi: 10.1111/cei.12565.

9.

Development and validation of protein microarray technology for simultaneous inflammatory mediator detection in human sera.

Selvarajah S, Negm OH, Hamed MR, Tubby C, Todd I, Tighe PJ, Harrison T, Fairclough LC.

Mediators Inflamm. 2014;2014:820304. doi: 10.1155/2014/820304. Epub 2014 Oct 14.

10.

Sex differences in the incidence of severe pain events following surgery: a review of 333,000 pain scores.

Tighe PJ, Riley JL 3rd, Fillingim RB.

Pain Med. 2014 Aug;15(8):1390-404. doi: 10.1111/pme.12498. Epub 2014 Jul 8.

PMID:
25039440
11.

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Aleskandarany MA, Negm OH, Green AR, Ahmed MA, Nolan CC, Tighe PJ, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2014 Jun;145(2):339-48. doi: 10.1007/s10549-014-2927-5. Epub 2014 Apr 26.

PMID:
24771047
12.

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).

Negm OH, Mannsperger HA, McDermott EM, Drewe E, Powell RJ, Todd I, Fairclough LC, Tighe PJ.

Eur J Immunol. 2014 Jul;44(7):2096-110. doi: 10.1002/eji.201344328. Epub 2014 Jun 10.

13.

Geospatial analysis of hospital consumer assessment of healthcare providers and systems pain management experience scores in U.S. hospitals.

Tighe PJ, Fillingim RB, Hurley RW.

Pain. 2014 May;155(5):1016-26. doi: 10.1016/j.pain.2014.02.003. Epub 2014 Feb 10.

PMID:
24525273
14.

Acute pain medicine in anesthesiology.

Boezaart AP, Munro AP, Tighe PJ.

F1000Prime Rep. 2013 Dec 3;5:54. doi: 10.12703/P5-54. Review.

15.

Of rough starts and smooth finishes: correlations between post-anesthesia care unit and postoperative days 1-5 pain scores.

Tighe PJ, Harle CA, Boezaart AP, Aytug H, Fillingim R.

Pain Med. 2014 Feb;15(2):306-15. doi: 10.1111/pme.12287. Epub 2013 Dec 5.

16.

Examination of publications from academic anesthesiology faculty in the United States.

Hurley RW, Zhao K, Tighe PJ, Ko PS, Pronovost PJ, Wu CL.

Anesth Analg. 2014 Jan;118(1):192-9. doi: 10.1213/ANE.0b013e3182a91aa9.

PMID:
24149582
17.

Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Wang J, Urbanowicz RA, Tighe PJ, Todd I, Corne JM, Fairclough LC.

PLoS One. 2013;8(3):e58556. doi: 10.1371/journal.pone.0058556. Epub 2013 Mar 11.

18.

A comparison of 4 airway devices on cervical spine alignment in cadaver models of global ligamentous instability at c1-2.

Wendling AL, Tighe PJ, Conrad BP, Baslanti TO, Horodyski M, Rechtine GR.

Anesth Analg. 2013 Jul;117(1):126-32. doi: 10.1213/ANE.0b013e318279b37a. Epub 2013 Jan 25.

19.

The evolution and practice of acute pain medicine.

Upp J, Kent M, Tighe PJ.

Pain Med. 2013 Jan;14(1):124-44. doi: 10.1111/pme.12015. Epub 2012 Dec 13. Review.

20.

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome.

Aleskandarany MA, Negm OH, Rakha EA, Ahmed MA, Nolan CC, Ball GR, Caldas C, Green AR, Tighe PJ, Ellis IO.

Breast Cancer Res Treat. 2012 Nov;136(2):419-27. doi: 10.1007/s10549-012-2249-4. Epub 2012 Oct 4.

PMID:
23053644
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk